fls.txt



item1.txt
Geographical revenue information is based on customers’ ship-to location.
The Company designates certain forward contracts as hedging instruments pursuant to Accounting Standards Codification (“ASC”) 815, Derivatives and Hedging (“ASC 815”).
The goodwill is not deductible for tax purposes.
Level 1 - Quoted (unadjusted) prices in active markets for identical assets or liabilities.
In determining the transaction price, the Company evaluates whether the price is subject to refund or adjustment to determine the net consideration to which it is expected to be entitled.
There were no stock options granted in the three and nine months ended March 30, 2019 and March 31, 2018.
authorizations by the Company’s Board of Directors for the repurchase of common stock were cancelled and superseded by this repurchase authorization.
The Chief Operating Decision Maker for the Company was assessed and determined to be the CEO.
During the measurement period, the Company gathered information and analyzed available guidance to more precisely compute the amount of the Transition Tax.
The adoption of Topic 606 has no impact on the total cash flows from operating, investing, or financing activities on the Condensed Consolidated Statements of Cash Flows.
The Company disagreed with the proposed transfer pricing adjustments and related penalties, and in September 2016, the Company filed a protest to challenge the proposed adjustments and request a conference with the Appeals Office of the IRS.
Therefore, none were excluded from the calculation of diluted earnings per share.
Employees are granted rights to acquire common stock under the 2008 ESPP.
The Act included Global Intangible Low-Taxed Income (“GILTI”) provisions, which first impact the Company in fiscal year 2019.
The weighted-average fair value of MSUs granted was $75.48 and $51.03 per share for the nine months ended March 30, 2019 and March 31, 2018, respectively.
Amortized discount and expenses, as well as interest expense associated with the notes, were $32.5 million and $37.1 million during the nine months ended March 30, 2019 and March 31, 2018, respectively.
Under the new standard, revenue is recognized when a customer obtains control of promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.
The Company's foreign currency forward contract gains or losses included in the Condensed Consolidated Statements of Income were not material for the three and nine months ended March 30, 2019 and March 31, 2018.


item2.txt
As of March 30, 2019, the Company had remaining authorization of $1.2 billion for future share repurchases.
The Company's prior repurchase authorization was cancelled and superseded by this repurchase authorization.
Research and development expenses were $330.1 million and $338.9 million for the nine months ended March 30, 2019 and March 31, 2018, respectively, which represented 18.8% and 18.3% of net revenues for each respective period.
Cash provided by investing activities was $785.4 million for the nine months ended March 30, 2019, compared with cash used in investing activities of $708.8 million for the nine months ended March 31, 2018, a change of $1.5 billion.
Cash provided by investing activities was $785.4 million for the nine months ended March 30, 2019, compared with cash used in investing activities of $708.8 million for the nine months ended March 31, 2018, a change of $1.5 billion.
In the fiscal quarter ended March 30, 2019, the Company repurchased approximately 2.2 million shares of its common stock for approximately $117.0 million.
Selling, general and administrative expenses were $74.1 million and $81.3 million for the three months ended March 30, 2019 and March 31, 2018, respectively, which represented 13.7% and 12.5% of net revenues for each respective period.
Cash provided by investing activities was $785.4 million for the nine months ended March 30, 2019, compared with cash used in investing activities of $708.8 million for the nine months ended March 31, 2018, a change of $1.5 billion.
Net revenues were $542.4 million and $648.6 million for the three months ended March 30, 2019 and March 31, 2018, respectively.


item3.txt



item4.txt
Our management, including the CEO and the CFO, has concluded that the Company’s disclosure controls and procedures were effective as of March 30, 2019.


part2.txt
The information set forth above under Part I, Item 1, Note 11 “Commitments and Contingencies” to the Condensed Consolidated Financial Statements is incorporated herein by reference.


